ARTL
ARTL

Artelo Biosciences Inc

NASDAQ · Pharmaceuticals
$1.47
+0.10 (+7.30%)
Day Range $1.35 — $1.51
52W Range $12.40 — $18.58
Open$1.40
Previous Close$1.37
Day High$1.51
Day Low$1.35
52W High$18.58
52W Low$12.40
Volume
Avg Volume70.8K
Market Cap2.97M
P/E Ratio18.47
EPS$0.76
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
0 Buy 3 Hold 3 Sell
Price Target +968.0% upside
Current
$1.47
Target
$15.70
$11.87 $15.70 avg $22.80
Key Financials
FY 2025 FY 2024 FY 2023
Revenue 653.2K 640.4K 651.1K
Net Income 176.4K 175.3K 172.4K
Profit Margin 27.0% 27.4% 26.5%
EBITDA 261.8K 256.2K 270.8K
Free Cash Flow 66.8K 83.8K 75.0K
Rev Growth -7.3% -5.3% +22.2%
Debt/Equity 0.34 0.30 0.32
Dividend
Dividend Yield3.00%
Annual Dividend$0.42
Payout Ratio55.5%
Frequencymonthly
Ex-DividendApr 16, 2026
Pay DateMay 2, 2026
Pharmaceuticals Peers
Symbol Name Price Change P/E Mkt Cap
LLY Eli Lilly and Co. $1,058.18 +3.66% 48.5 1.00T
JNJ Johnson & Johnson $239.99 +0.93% 21.6 578.21B
MRK Merck & Co. Inc. $121.93 +1.82% 16.6 302.63B
PFE Pfizer Inc. $27.22 +2.76% 19.9 154.76B
BMY Bristol-Myers Squibb Co $61.99 +4.15% 17.9 126.20B
ZTS Zoetis Inc $127.42 +0.54% 21.5 56.95B
ARTL News

No news for ARTL yet

Quick Stats
Market Cap2.97M
P/E Ratio18.47
EPS$0.76
Div Yield3.00%
Volume
SectorPharmaceuticals